FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Terry Lybrand

Research Profile

Concepts & Ideas

Chemicals & Drugs

Genes & Molecular Sequences

Amino Acid Sequences

Phenomena

Co-author Network

Publications

TOP 3
Loren Baugh; David S Cerutti; Susanne Gülich; Isolde Le Trong; Nital Mehta; Patrick S Stayton; Ronald E Stenkamp; Terry P Lybrand
Second-contact shell mutation diminishes streptavidin-biotin binding affinity through transmitted effects on equilibrium dynamics.
Isolde Le Trong; Terry P Lybrand; Patrick S Stayton; David E Hyre; Zhizhi Wang; Ronald E Stenkamp
Streptavidin and its biotin complex at atomic resolution.
Sunghoon Kim; Suzanne Brandon; Zheng Zhou; Charles E Cobb; Sarah J Edwards; Christopher W Moth; Christian S Parry; Jarrod A Smith; Terry P Lybrand; Eric J Hustedt; Albert H Beth
Determination of structural models of the complex between the cytoplasmic domain of erythrocyte band 3 and ankyrin-R repeats 13-24.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Terry Lybrand (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Loren Baugh; David S Cerutti; Susanne Gülich; Isolde Le Trong; Nital Mehta; Patrick S Stayton; Ronald E Stenkamp; Terry P Lybrand
Second-contact shell mutation diminishes streptavidin-biotin binding affinity through transmitted effects on equilibrium dynamics.
Biochemistry 2012;51(2):597-607.
2011: Isolde Le Trong; Terry P Lybrand; Patrick S Stayton; David E Hyre; Zhizhi Wang; Ronald E Stenkamp
Streptavidin and its biotin complex at atomic resolution.
Acta crystallographica. Section D, Biological crystallography 2011;67(Pt 9):813-21.
2011: Sunghoon Kim; Suzanne Brandon; Zheng Zhou; Charles E Cobb; Sarah J Edwards; Christopher W Moth; Christian S Parry; Jarrod A Smith; Terry P Lybrand; Eric J Hustedt; Albert H Beth
Determination of structural models of the complex between the cytoplasmic domain of erythrocyte band 3 and ankyrin-R repeats 13-24.
The Journal of biological chemistry 2011;286(23):20746-57.
2010: Loren Baugh; Isolde Le Trong; David S Cerutti; Susanne Gülich; Patrick S Stayton; Ronald E Stenkamp; Terry P Lybrand
A distal point mutation in the streptavidin-biotin complex preserves structure but diminishes binding affinity: experimental evidence of electronic polarization effects?
Biochemistry 2010;49(22):4568-70.
2009: Usha K Muppirala; Susan Desensi; Terry P Lybrand; Gerald L Hazelbauer; Zhijun Li
Molecular modeling of flexible arm-mediated interactions between bacterial chemoreceptors and their modification enzyme.
Protein science : a publication of the Protein Society 2009;18(8):1702-14.
2009: David S Cerutti; Isolde Le Trong; Ronald E Stenkamp; Terry P Lybrand
Dynamics of the streptavidin-biotin complex in solution and in its crystal lattice: distinct behavior revealed by molecular simulations.
The journal of physical chemistry. B 2009;113(19):6971-85.
2008: David S Cerutti; Isolde Le Trong; Ronald E Stenkamp; Terry P Lybrand
Simulations of a protein crystal: explicit treatment of crystallization conditions links theory and experiment in the streptavidin-biotin complex.
Biochemistry 2008;47(46):12065-77.
2008: Andrew S Felts; Brianna S Siegel; Shiu M Young; Christopher W Moth; Terry P Lybrand; Andrew J Dannenberg; Lawrence J Marnett; Kotha Subbaramaiah
Sulindac derivatives that activate the peroxisome proliferator-activated receptor gamma but lack cyclooxygenase inhibition.
Journal of medicinal chemistry 2008;51(16):4911-9.
2008: Susan C Desensi; David P Rangel; Albert H Beth; Terry P Lybrand; Eric J Hustedt
Simulation of nitroxide electron paramagnetic resonance spectra from brownian trajectories and molecular dynamics simulations.
Biophysical journal 2008;94(10):3798-809.
2007: Rachel E Rigsby; Daniel W Brown; Eric Dawson; Terry P Lybrand; Richard N Armstrong
A model for glutathione binding and activation in the fosfomycin resistance protein, FosA.
Archives of biochemistry and biophysics 2007;464(2):277-83.
2006: Kaleeckal harikumar; Maoqing Dong; Zhijie Cheng; Delia I Pinon; Terry P Lybrand; Laurence J Miller
Transmembrane segment peptides can disrupt cholecystokinin receptor oligomerization without affecting receptor function.
Biochemistry 2006;45(49):14706-16.
2006: Kristina E Furse; Derek A Pratt; Claus Schneider; Alan R Brash; Ned A Porter; Terry P Lybrand
Molecular dynamics simulations of arachidonic acid-derived pentadienyl radical intermediate complexes with COX-1 and COX-2: insights into oxygenation regio- and stereoselectivity.
Biochemistry 2006;45(10):3206-18.
2006: Kristina E Furse; Derek A Pratt; Ned A Porter; Terry P Lybrand
Molecular dynamics simulations of arachidonic acid complexes with COX-1 and COX-2: insights into equilibrium behavior.
Biochemistry 2006;45(10):3189-205.
2006: Elizabeth M Hadac; Eric S Dawson; James W Darrow; Elizabeth E Sugg; Terry P Lybrand; Laurence J Miller
Novel benzodiazepine photoaffinity probe stereoselectively labels a site deep within the membrane-spanning domain of the cholecystokinin receptor.
Journal of medicinal chemistry 2006;49(3):850-63.
2006: Wing-Cheung Lai; Megan L Peach; Terry P Lybrand; Gerald L Hazelbauer
Diagnostic cross-linking of paired cysteine pairs demonstrates homologous structures for two chemoreceptor domains with low sequence identity.
Protein science : a publication of the Protein Society 2006;15(1):94-101.
2005: Aaron N Hata; Terry P Lybrand; Richard M Breyer
Identification of determinants of ligand binding affinity and selectivity in the prostaglandin D2 receptor CRTH2.
The Journal of biological chemistry 2005;280(37):32442-51.
2005: Christopher W Moth; Jeffery J Prusakiewicz; Lawrence J Marnett; Terry P Lybrand
Stereoselective binding of indomethacin ethanolamide derivatives to cyclooxygenase-1.
Journal of medicinal chemistry 2005;48(10):3613-20.
2005: Aaron N Hata; Terry P Lybrand; Lawrence J Marnett; Richard M Breyer
Structural determinants of arylacetic acid nonsteroidal anti-inflammatory drugs necessary for binding and activation of the prostaglandin D2 receptor CRTH2.
Molecular pharmacology 2005;67(3):640-7.
2004: Tammy L Wingo; Vikas N Shah; Mark E Anderson; Terry P Lybrand; Walter J Chazin; Jeffrey R Balser
An EF-hand in the sodium channel couples intracellular calcium to cardiac excitability.
Nature structural & molecular biology 2004;11(3):219-25.
2004: Maoqing Dong; Zhijun Li; Delia I Pinon; Terry P Lybrand; Laurence J Miller
Spatial approximation between the amino terminus of a peptide agonist and the top of the sixth transmembrane segment of the secretin receptor.
The Journal of biological chemistry 2004;279(4):2894-903.
2004: Kaleeckal harikumar; Delia I Pinon; William Wessels; Eric S Dawson; Terry P Lybrand; Franklyn G Prendergast; Laurence J Miller
Measurement of intermolecular distances for the natural agonist Peptide docked at the cholecystokinin receptor expressed in situ using fluorescence resonance energy transfer.
Molecular pharmacology 2004;65(1):28-35.
2003: Maoqing Dong; Zhijun Li; Mengwei Zang; Delia I Pinon; Terry P Lybrand; Laurence J Miller
Spatial approximation between two residues in the mid-region of secretin and the amino terminus of its receptor. Incorporation of seven sets of such constraints into a three-dimensional model of the agonist-bound secretin receptor.
The Journal of biological chemistry 2003;278(48):48300-12.
2003: Kristina E Furse; Terry P Lybrand
Three-dimensional models for beta-adrenergic receptor complexes with agonists and antagonists.
Journal of medicinal chemistry 2003;46(21):4450-62.
2003: Mengwei Zang; Maoqing Dong; Delia I Pinon; Xi-Qin Ding; Elizabeth M Hadac; Zhijun Li; Terry P Lybrand; Laurence J Miller
Spatial approximation between a photolabile residue in position 13 of secretin and the amino terminus of the secretin receptor.
Molecular pharmacology 2003;63(5):993-1001.
2002: Eric S Dawson; Randel M Henne; Laurence J Miller; Terry P Lybrand
Moleular models for cholecystokinin-A receptor.
Pharmacology & toxicology 2002;91(6):290-6.
2002: Laurence J Miller; Terry P Lybrand
Molecular basis of agonist binding to the type A cholecystokinin receptor.
Pharmacology & toxicology 2002;91(6):282-5.
2002: Maoqing Dong; Mengwei Zang; Delia I Pinon; Zhijun Li; Terry P Lybrand; Laurence J Miller
Interaction among four residues distributed through the secretin pharmacophore and a focused region of the secretin receptor amino terminus.
Molecular endocrinology (Baltimore, Md.) 2002;16(11):2490-501.
2002: David E Hyre; Lynn M Amon; Julie E Penzotti; Isolde Le Trong; Ronald E Stenkamp; Terry P Lybrand; Patrick S Stayton
Early mechanistic events in biotin dissociation from streptavidin.
Nature structural biology 2002;9(8):582-5.
2002: Xi-Qin Ding; Delia I Pinon; Kristina E Furse; Terry P Lybrand; Laurence J Miller
Refinement of the conformation of a critical region of charge-charge interaction between cholecystokinin and its receptor.
Molecular pharmacology 2002;61(5):1041-52.
2002: Carani B Sanjeevi; Terry P Lybrand; S Stevanovic; H G Rammensee
Molecular modeling of eluted peptides from DQ6 molecules (DQB1*0602 and DQB1*0604) negatively and positively associated with type 1 diabetes.
Annals of the New York Academy of Sciences 2002;958():317-20.
2002: Megan L Peach; Gerald L Hazelbauer; Terry P Lybrand
Modeling the transmembrane domain of bacterial chemoreceptors.
Protein science : a publication of the Protein Society 2002;11(4):912-23.
2001: Xi-Qin Ding; V Dolu; Elizabeth M Hadac; Eileen L Holicky; Delia I Pinon; Terry P Lybrand; Laurence J Miller
Refinement of the structure of the ligand-occupied cholecystokinin receptor using a photolabile amino-terminal probe.
The Journal of biological chemistry 2001;276(6):4236-44.
1999: Patrick S Stayton; Stefanie Freitag; Lisa A Klumb; A Chilkoti; Vano Chu; Julie E Penzotti; Richard To; David E Hyre; Isolde Le Trong; Terry P Lybrand; Ronald E Stenkamp
Streptavidin-biotin binding energetics.
Biomolecular engineering 1999;16(1-4):39-44.
1999: Benjamin J McFarland; Andrea J Sant; Terry P Lybrand; Craig Beeson
Ovalbumin(323-339) peptide binds to the major histocompatibility complex class II I-A(d) protein using two functionally distinct registers.
Biochemistry 1999;38(50):16663-70.
1999: Stefanie Freitag; Vano Chu; Julie E Penzotti; Lisa A Klumb; Richard To; David E Hyre; Isolde Le Trong; Terry P Lybrand; Ronald E Stenkamp; Patrick S Stayton
A structural snapshot of an intermediate on the streptavidin-biotin dissociation pathway.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(15):8384-9.
1999: Elizabeth M Hadac; Z Ji; Delia I Pinon; Randel M Henne; Terry P Lybrand; Laurence J Miller
A peptide agonist acts by occupation of a monomeric G protein-coupled receptor: dual sites of covalent attachment to domains near TM1 and TM7 of the same molecule make biologically significant domain-swapped dimerization unlikely.
Journal of medicinal chemistry 1999;42(12):2105-11.
1998: D G Doherty; Julie E Penzotti; David M Koelle; William W Kwok; Terry P Lybrand; Susan A Masewicz; Gerald Nepom
Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(7):3527-35.
1998: Peter Hjelmstrom; Julie E Penzotti; Randel M Henne; Terry P Lybrand
A molecular model of myelin oligodendrocyte glycoprotein.
Journal of neurochemistry 1998;71(4):1742-9.
1998: Elizabeth M Hadac; Delia I Pinon; Z Ji; Eileen L Holicky; Randel M Henne; Terry P Lybrand; Laurence J Miller
Direct identification of a second distinct site of contact between cholecystokinin and its receptor.
The Journal of biological chemistry 1998;273(21):12988-93.
1998: Peter Hjelmstrom; C DeWeese-Scott; Julie E Penzotti; Terry P Lybrand; Carani B Sanjeevi
Structural differences between HLA-DQ molecules associated with myasthenia gravis characterized by molecular modeling.
Journal of neuroimmunology 1998;85(1):102-5.
1997: Z Ji; Elizabeth M Hadac; Randel M Henne; S A Patel; Terry P Lybrand; Laurence J Miller
Direct identification of a distinct site of interaction between the carboxyl-terminal residue of cholecystokinin and the type A cholecystokinin receptor using photoaffinity labeling.
The Journal of biological chemistry 1997;272(39):24393-401.
1997: Carani B Sanjeevi; C DeWeese; Mona Landin-Olsson; Ingrid Kockum; G Dahlquist; A Lernmark; Terry P Lybrand
Analysis of critical residues of HLA-DQ6 molecules in insulin-dependent diabetes mellitus.
Tissue antigens 1997;50(1):61-5.
1997: Julie E Penzotti; Gerald Nepom; Terry P Lybrand
Use of T cell receptor/HLA-DRB1*04 molecular modeling to predict site-specific interactions for the DR shared epitope associated with rheumatoid arthritis.
Arthritis and rheumatism 1997;40(7):1316-26.
1996: M Kontoyianni; C DeWeese; Julie E Penzotti; Terry P Lybrand
Three-dimensional models for agonist and antagonist complexes with beta 2 adrenergic receptor.
Journal of medicinal chemistry 1996;39(22):4406-20.
1996: R R Annand; M Kontoyianni; Julie E Penzotti; T Dudler; Terry P Lybrand; Michael H Gelb
Active site of bee venom phospholipase A2: the role of histidine-34, aspartate-64 and tyrosine-87.
Biochemistry 1996;35(14):4591-601.
1996: Carani B Sanjeevi; P Höök; Mona Landin-Olsson; Ingrid Kockum; G Dahlquist; Terry P Lybrand; A Lernmark
DR4 subtypes and their molecular properties in a population-based study of Swedish childhood diabetes.
Tissue antigens 1996;47(4):275-83.
1996: Julie E Penzotti; D Doherty; Terry P Lybrand; Gerald Nepom
A structural model for TCR recognition of the HLA class II shared epitope sequence implicated in susceptibility to rheumatoid arthritis.
Journal of autoimmunity 1996;9(2):287-93.
1996: Gerald Nepom; Dawei Ou; Terry P Lybrand; C DeWeese; M E Domeier; J H Buckner; Leslie Ann Mitchell; Aubrey J Tingle
Recognition of altered self major histocompatibility complex molecules modulated by specific peptide interactions.
European journal of immunology 1996;26(4):949-52.
1996: T J Callahan; E Swanson; Terry P Lybrand
MD Display: an interactive graphics program for visualization of molecular dynamics trajectories.
Journal of molecular graphics 1996;14(1):39-41, 32.
1996: E Swanson; Terry P Lybrand
Computational biology instruction at the University of Washington Center for Bioengineering.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 1996;():590-8.
1995: Terry P Lybrand
Ligand-protein docking and rational drug design.
Current opinion in structural biology 1995;5(2):224-8.
1995: Carani B Sanjeevi; Terry P Lybrand; C DeWeese; Mona Landin-Olsson; Ingrid Kockum; G Dahlquist; G Sundkvist; D Stenger; A Lernmark
Polymorphic amino acid variations in HLA-DQ are associated with systematic physical property changes and occurrence of IDDM. Members of the Swedish Childhood Diabetes Study.
Diabetes 1995;44(1):125-31.
1994: Carani B Sanjeevi; Terry P Lybrand; Mona Landin-Olsson; Ingrid Kockum; G Dahlquist; William Hagopian; Jerry P Palmer; A Lernmark
Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus.
Tissue antigens 1994;44(2):110-9.
1992: K MaloneyHuss; Terry P Lybrand
Three-dimensional structure for the beta 2 adrenergic receptor protein based on computer modeling studies.
Journal of molecular biology 1992;225(3):859-71.
1991: Terry P Lybrand
Molecular simulation and drug design.
Journal de pharmacie de Belgique 1991;46(1):49-54.